154 related articles for article (PubMed ID: 2538461)
1. Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites.
Tessner TG; O'Flaherty JT; Wykle RL
J Biol Chem; 1989 Mar; 264(9):4794-9. PubMed ID: 2538461
[TBL] [Abstract][Full Text] [Related]
2. Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2.
Billah MM; Bryant RW; Siegel MI
J Biol Chem; 1985 Jun; 260(11):6899-906. PubMed ID: 3922982
[TBL] [Abstract][Full Text] [Related]
3. An arachidonoyl (polyenoic)-specific phospholipase A2 activity regulates the synthesis of platelet-activating factor in granulocytic HL-60 cells.
Suga K; Kawasaki T; Blank ML; Snyder F
J Biol Chem; 1990 Jul; 265(21):12363-71. PubMed ID: 2115518
[TBL] [Abstract][Full Text] [Related]
4. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
5. 1-O-alkyl-2-N-methylcarbamyl-glycerophosphocholine: a biologically potent, non-metabolizable analog of platelet-activating factor.
O'Flaherty JT; Redman JF; Schmitt JD; Ellis JM; Surles JR; Marx MH; Piantadosi C; Wykle RL
Biochem Biophys Res Commun; 1987 Aug; 147(1):18-24. PubMed ID: 2820395
[TBL] [Abstract][Full Text] [Related]
6. Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil.
Fonteh AN; Winkler JD; Torphy TJ; Heravi J; Undem BJ; Chilton FH
J Immunol; 1993 Jul; 151(1):339-50. PubMed ID: 8392098
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
[TBL] [Abstract][Full Text] [Related]
8. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction.
Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils.
McIntyre TM; Reinhold SL; Prescott SM; Zimmerman GA
J Biol Chem; 1987 Nov; 262(32):15370-6. PubMed ID: 2824456
[TBL] [Abstract][Full Text] [Related]
10. Separation of agonist-stimulated arachidonate mobilization from subsequent leukotriene B4 synthesis in human neutrophils: different effects of oleoylacetylglycerol and phorbol myristate acetate as priming agents.
Rosenthal MD; Franson RC
J Cell Physiol; 1994 Sep; 160(3):522-30. PubMed ID: 8077290
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet-activating factor biosynthesis via the acetyltransferase by arachidonic and oleic acids in ionophore A23187-stimulated bovine neutrophils.
Remy E; Lenoir G; Houben A; Vandesteene C; Remacle J
Biochim Biophys Acta; 1989 Sep; 1005(1):87-92. PubMed ID: 2505852
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells.
Chepenik KP; Wykle RL
Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes.
Ramesha CS; Pickett WC
J Biol Chem; 1986 Nov; 261(33):15519-23. PubMed ID: 3096991
[TBL] [Abstract][Full Text] [Related]
14. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
Bauldry SA; Wooten RE
Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
[TBL] [Abstract][Full Text] [Related]
16. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139
[TBL] [Abstract][Full Text] [Related]
17. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.
Chilton FH; Ellis JM; Olson SC; Wykle RL
J Biol Chem; 1984 Oct; 259(19):12014-9. PubMed ID: 6434535
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid.
Garcia MC; Fernandez-Gallardo S; Gijon MA; Garcia C; Nieto ML; Sanchez Crespo M
Biochem J; 1990 May; 268(1):91-8. PubMed ID: 1693077
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cells.
Sugatani J; Miwa M; Komiyama Y; Ito S
J Lipid Mediat Cell Signal; 1996 Jan; 13(1):73-88. PubMed ID: 8998599
[TBL] [Abstract][Full Text] [Related]
20. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
McDonald PP; McColl SR; Braquet P; Borgeat P
Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]